Phase 1 study shows encouraging data for gene replacement therapy for SMA type I
A one-time intravenous infusion of the high dose of gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published today in the New England ...
Nov 1, 2017
0
242